China Cord Blood Lands $50 Million from Golden Meditech

China Cord Blood Corp. announced that its corporate parent, Golden Meditech Holdings, would invest another $50 million in China Cord Blood, allowing it to expand its business – perhaps beyond China. Golden Meditech already owns 42% of CCBC. The new investment is a convertible bond that can be converted into another 15.5% of the company. CCBC seems to already have a lot of cash.  More details.... Stock Symbols: (NYSE: CO) (HK: 801; TW: 910801) Share this with colleagues: var switchTo5x=true; stLight.options({publisher:'d7871f5b-67bc-4d30-b66f-1465d0b97213'});